Welcome to LookChem.com Sign In|Join Free
  • or
(S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoic acid is a complex chiral chemical compound characterized by its cyclohexyl ureido group and a tert-butylsulfonylMethyl group. As a specified (S)-stereoisomer, this synthetic organic molecule is potentially designed for pharmaceutical or research applications, where its intricate structure and functional groups may allow for specific interactions with biological targets. This makes it a candidate for drug discovery and biochemical research.

1208245-85-5

Post Buying Request

1208245-85-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1208245-85-5 Usage

Uses

Used in Pharmaceutical Industry:
(S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoic acid is used as a potential drug candidate for its ability to interact with biological targets due to its ureido and sulfonylMethyl groups, which may be crucial for the development of new medications.
Used in Biochemical Research:
In the field of biochemistry, (S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoic acid serves as a valuable compound for studying molecular interactions and the development of targeted therapies, given its complex structure and specific functional groups.

Check Digit Verification of cas no

The CAS Registry Mumber 1208245-85-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,8,2,4 and 5 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1208245-85:
(9*1)+(8*2)+(7*0)+(6*8)+(5*2)+(4*4)+(3*5)+(2*8)+(1*5)=135
135 % 10 = 5
So 1208245-85-5 is a valid CAS Registry Number.

1208245-85-5Relevant academic research and scientific papers

ENANTIO- AND STEREO-SPECIFIC SYNTHESES OF β-AMINO-α- HYDROXY AMIDES

-

, (2011/02/24)

Processes useful for the preparation of a Compound of Formula I: Formula (I). Intermediates useful for the preparation of the compound of Formula I, and processes useful for preparing said intermediates are disclosed.

Discovery of narlaprevir (SCH 900518): A potent, second generation HCV NS3 serine protease inhibitor

Arasappan, Ashok,Bennett, Frank,Bogen, Stephane L.,Venkatraman, Srikanth,Blackman, Melissa,Chen, Kevin X.,Hendrata, Siska,Huang, Yuhua,Huelgas, Regina M.,Nair, Latha,Padilla, Angela I.,Pan, Weidong,Pike, Russell,Pinto, Patrick,Ruan, Sumei,Sannigrahi, Mousumi,Velazquez, Francisco,Vibulbhan, Bancha,Wu, Wanli,Yang, Weiying,Saksena, Anil K.,Girijavallabhan, Viyyoor,Shih, Neng-Yang,Kong, Jianshe,Meng, Tao,Jin, Yan,Wong, Jesse,McNamkra, Paul,Prongay, Andrew,Madison, Vincent,Piwinski, John J.,Cheng, Kuo-Chi,Morrison, Richard,Malcolm, Bruce,Tong, Xiao,Ralston, Robert,Njoroge, F. George

scheme or table, p. 64 - 69 (2010/12/29)

Boceprevir (SCH 503034), 1, a novel HCV NS3 serine protease inhibitor discovered in our laboratories, is currently undergoing phase III clinical trials. Detailed investigations toward a second generation protease inhibitor culminated in the discovery of narlaprevir (SCH 900518), 37, with improved potency (～10-fold over 1), pharmacokinetic profile and physicochemical characteristics, currently in phase II human trials. Exploration of synthetic sequence for preparation of 37 resulted in a route that required no silica gel purification for the entire synthesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1208245-85-5